Following the October 28, 2015 voluntary recall by Sanofi-aventis Canada Inc. (Sanofi Canada) of all lots of Allerject epinephrine auto-injectors of both the 0.15 mg/0.15ml and 0.30 mg/0.3 ml strengths, and given the recent announcement that stock of alternative epinephrine auto-injectors is now sufficient to replace all Allerject devices in Canada, Sanofi Canada is notifying the public of the following:
1. Canadian customers are instructed to immediately return all Allerject devices to their local pharmacy.
2. Previous recommendations to limit the number of devices that can be replaced for an alternative auto-injector are now removed as a result of the announcement that supply of the alternative product is sufficient to satisfy the demand.
3. All Allerject epinephrine auto-injectors returned by patients to their pharmacist with an expiry date between October 2015 and December 2016 inclusively continue to be eligible for replacement at no cost to the patient.
No comments:
Post a Comment